Interleukin-2 for anti-cancer therapy
Hamblin, T.J.
Comprehensive Therapy 17(12): 35-38
1991
ISSN/ISBN: 0098-8243 PMID: 1790664 Document Number: 377545
Document emailed within 1 workday
Related Documents
Vuist, W.M.; v Buitenen, F.; de Rie, M.A.; Hekman, A.; Rümke, P.; Melief, C.J. 1989: Potentiation by interleukin 2 of Burkitt's lymphoma therapy with anti-pan B (anti-CD19) monoclonal antibodies in a mouse xenotransplantation model Cancer Research 49(14): 3783-3788Lotze, M.T.; Hellerstedt, B.; Stolinski, L.; Tueting, T.; Wilson, C.; Kinzler, D.; Vu, H.; Rubin, J.T.; Storkus, W.; Tahara, H.; Elder, E.; Whiteside, T. 1997: The role of interleukin-2, interleukin-12, and dendritic cells in cancer therapy Cancer Journal from Scientific American 3(Suppl 1): S109-S114
Wissing, K.M.; Desalle, F.; Abramowicz, D.; Willems, F.; Leo, O.; Goldman, M.; Alegre, M.L. 1999: Down-regulation of interleukin-2 and interferon-gamma and maintenance of interleukin-4 and interleukin-10 production after administration of an anti-CD3 monoclonal antibody in mice Transplantation 68(5): 677-684
Bubeník, J.; Símová, J.; Zeuthen, J.; Diamant, M.; Jandlová, T.; Bubeníková, D. 1994: Gene therapy of plasmacytoma: comparison of the therapeutic efficacy of tumour cells transduced with the interleukin-2, interleukin-4, or interleukin-6 genes Folia Biologica 40(1-2): 29-36
Kupiec-Weglinski, J.W.; Hahn, H.J.; Kirkman, R.L.; Volk, H.D.; Mouzaki, A.; DiStefano, R.; Tellides, G.; Dallman, M.; Morris, P.J.; Strom, T.B. 1988: Cyclosporine potentiates the immunosuppressive effects of anti-interleukin 2 receptor monoclonal antibody therapy Transplantation Proceedings 20(2 Suppl 2): 207-216
Ward, L.D.; Shi, P.T.; Simpson, R.J. 1992: Binding of anti-human-interleukin-6 monoclonal antibodies to synthetic peptides of human interleukin-6 studied using surface plasmon resonance Biochemistry International 26(3): 559-565
Oettgen, H.F. 1987: Interferons, interleukin-2 and tumor necrosis factor. new approaches to cancer therapy Arzneimittel-Forschung 37(2a): 251-255
Liang, H.-m.; Jiang, J.; Kong, B.-h.; Ma, D.-x.; Jiang, S. 2003: Study of the therapeutic effects of costimulatory molecules B7-1 and interleukin 12 modified tumor cells vaccines on ovarian epithelial carcinoma through induction of anti-cancer immunity of the body Zhonghua Fu Chan Ke Za Zhi 38(6): 354-358
Wirth, M. 1991: The value of interferons, interleukin-2 and tumor necrosis factor in the therapy of renal cell cancer Der Urologe. Ausg. a 30(2): 77-80
Zhang, T.; Kazuyoshi, K.; Mahboob, H.Qureshi.; Tang, Y.; Atsushi, S. 2003: Combined therapy of interleukin-12 and interleukin-18 against Cryptococcus neoformans infection in a murine model Chinese Medical Journal 116(5): 669-672
Gollnick, S.O.; Liu, X.; Owczarczak, B.; Musser, D.A.; Henderson, B.W. 1997: Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo Cancer Research 57(18): 3904-3909
Singh, H.; Sachan, R.; Goel, H.; Mittal, B. 2008: Genetic variants of interleukin-1RN and interleukin-1beta genes and risk of cervical cancer Bjog: An International Journal of Obstetrics and Gynaecology 115(5): 633-638
Kuo, J.Y.; Ohmoto, Y.; Yoshida, O. 1996: An assessment of interleukin-1 alpha and interleukin-1 beta production in patients with bladder cancer Anticancer Research 16(5b): 3067-3070
Sievers, E.L.; Lange, B.J.; Sondel, P.M.; Krailo, M.D.; Gan, J.; Tjoa, T.; Liu-Mares, W.; Feig, S.A. 2000: Children's cancer group trials of interleukin-2 therapy to prevent relapse of acute myelogenous leukemia Cancer Journal from Scientific American 6(Suppl): S39-S44
Dawood, F.A.; Moreira, S.S.; Dancona, C.; Shimizu, L.T. 1989: Reduction of interleukin 1 and interleukin 2 production by patients with advanced cancer Brazilian Journal of Medical and Biological Research 22(10): 1259-1270
Inanir, A.; Ozoran, K.; Tutkak, H.; Mermerci, B. 2004: The effects of calcitriol therapy on serum interleukin-1, interleukin-6 and tumour necrosis factor-alpha concentrations in post-menopausal patients with osteoporosis Journal of International Medical Research 32(6): 570-582
Ecker-Schlipf, B. 1994: Anti-hormonal therapy in breast cancer Medizinische Monatsschrift für Pharmazeuten 17(8): 247-250
Taira, T.; Yamamoto, N. 2012: Anti-VEGF therapy for lung cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 70(12): 2159-2164
Chen, D.; Carter, T.H.; Auborn, K.J. 2004: Apoptosis in cervical cancer cells: implications for adjunct anti-estrogen therapy for cervical cancer Anticancer Research 24(5a): 2649-2656
El-Amrani, M.; Aidi, S.; Amarenco, P. 2003: Cerebral ischemic events and anti-cancer therapy Revue Neurologique (Paris) 159(4): 371-380